Asensus Surgical Top Management
Asensus Surgical employs about 160 people. The company is managed by 14 executives with a total tenure of roughly 130 years, averaging almost 9.0 years of service per executive, having 11.43 employees per reported executive. Evaluation of Asensus Surgical's management performance can provide insight into the firm performance.
| Todd Pope CEO CEO and President and Director |
| Paul LaViolette Chairman Independent Chairman of the Board |
Asensus |
Asensus Surgical Management Team Effectiveness
The company has return on total asset (ROA) of (44.58) % which means that it has lost $44.58 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (94.1) %, meaning that it created substantial loss on money invested by shareholders. Asensus Surgical's management efficiency ratios could be used to measure how well Asensus Surgical manages its routine affairs as well as how well it operates its assets and liabilities.Asensus Surgical Workforce Comparison
Asensus Surgical is currently regarded as top stock in number of employees category among related companies. The total workforce of Medical Devices industry is at this time estimated at about 144,661. Asensus Surgical adds roughly 160 in number of employees claiming only tiny portion of all equities under Medical Devices industry.
Asensus Surgical Notable Stakeholders
An Asensus Surgical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Asensus Surgical often face trade-offs trying to please all of them. Asensus Surgical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Asensus Surgical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Todd Pope | CEO and President and Director | Profile | |
| Paul LaViolette | Independent Chairman of the Board | Profile | |
| Joseph Slattery | CFO, Principal Accounting Officer and Executive VP | Profile | |
| Anthony Fernando | COO | Profile | |
| David Milne | Independent Director | Profile | |
| Aftab Kherani | Independent Director | Profile | |
| Richard Pfenniger | Independent Director | Profile | |
| Dennis Dougherty | Independent Director | Profile | |
| William Starling | Independent Director | Profile | |
| Andrea Biffi | Director | Profile | |
| William Kelley | Independent Director | Profile | |
| Jane Hsiao | Independent Director | Profile | |
| Paul Ziegler | VP of Sales | Profile | |
| Eric Smith | Chief Commercial Officer | Profile |
Asensus Surgical Workforce Analysis
Traditionally, organizations such as Asensus Surgical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Asensus Surgical within its industry.Asensus Surgical Manpower Efficiency
Return on Asensus Surgical Manpower
| Revenue Per Employee | 17.2K | |
| Revenue Per Executive | 196.4K | |
| Net Loss Per Employee | 374.8K | |
| Net Loss Per Executive | 4.3M | |
| Working Capital Per Employee | 112.9K | |
| Working Capital Per Executive | 1.3M |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Consideration for investing in Asensus Stock
If you are still planning to invest in Asensus Surgical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Asensus Surgical's history and understand the potential risks before investing.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |